Clinical Trials Directory

Trials / Completed

CompletedNCT06582030

Stop Addiction Stigma

Stop Addiction Stigma Training Workshop With Case Vignettes to Decrease Stigmatizing Attitudes Toward People With Substance Abuse Disorders

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
93 (actual)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This clinical trial evaluates the impact of a Stop Addiction Stigma (SAS) training workshop with a short description of the conditions related to addiction (vignettes) on stigmatizing attitudes toward individuals with substance abuse disorders. Reviews have shown that patients with substance abuse disorders have experienced negative attitudes from their health care providers. Negative attitudes may lead to less involvement from the provider and the patient and may lead to less effective care. Using case vignettes with a SAS workshop may be an effective method to help people learn about addiction, reduce the stigma toward addiction and improve the quality of health care.

Detailed description

PRIMARY OBJECTIVE: I. To describe the impact of SAS training on participants' responses to people with a substance impairment. SECONDARY OBJECTIVES: I. To evaluate the feasibility of stigma training workshops on stigmatizing attitudes health care personnel. II. To explore the maintainability of responses over time. III. To explore relationships between language and stigmatizing attitudes. OUTLINE: Participants are randomized to 1 of 6 group case vignettes. GROUP A (CHRONICALLY RELAPSING BRAIN DISEASE): Participants view the chronically relapsing brain disease vignette and attend a SAS workshop on study. GROUP B (BRAIN DISEASE): Participants view the brain disease vignette and attend a SAS workshop on study. GROUP C (DISEASE): Participants view the disease vignette and attend a SAS workshop on study. GROUP D (ILLNESS): Participants view the illness vignette and attend a SAS workshop on study. GROUP E (DISORDER): Participants view the disorder vignette and attend a SAS workshop on study. GROUP F (PROBLEM): Participants view the problem vignette and attend a SAS workshop on study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALAssessmentAncillary studies
OTHEREducational ActivityView the chronically relapsing brain disease vignette
OTHEREducational ActivityView the brain disease vignette
OTHEREducational ActivityView the disease vignette
OTHEREducational ActivityView the illness vignette
OTHEREducational ActivityView the disorder vignette
OTHEREducational ActivityView the problem vignette
OTHERTrainingAttend a SAS workshop

Timeline

Start date
2023-10-17
Primary completion
2023-12-31
Completion
2023-12-31
First posted
2024-09-03
Last updated
2024-09-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06582030. Inclusion in this directory is not an endorsement.